Cathepsin B in antigen-presenting cells controls mediators of the Th1 immune response during Leishmania major infection

PLoS Negl Trop Dis. 2014 Sep 25;8(9):e3194. doi: 10.1371/journal.pntd.0003194. eCollection 2014 Sep.

Abstract

Resistance and susceptibility to Leishmania major infection in the murine model is determined by the capacity of the host to mount either a protective Th1 response or a Th2 response associated with disease progression. Previous reports involving the use of cysteine cathepsin inhibitors indicated that cathepsins B (Ctsb) and L (Ctsl) play important roles in Th1/Th2 polarization during L. major infection in both susceptible and resistant mouse strains. Although it was hypothesized that these effects are a consequence of differential patterns of antigen processing, the mechanisms underlying these differences were not further investigated. Given the pivotal roles that dendritic cells and macrophages play during Leishmania infection, we generated bone-marrow derived dendritic cells (BMDC) and macrophages (BMM) from Ctsb-/- and Ctsl-/- mice, and studied the effects of Ctsb and Ctsl deficiency on the survival of L. major in infected cells. Furthermore, the signals used by dendritic cells to instruct Th cell polarization were addressed: the expression of MHC class II and co-stimulatory molecules, and cytokine production. We found that Ctsb-/- BMDC express higher levels of MHC class II molecules than wild-type (WT) and Ctsl-/- BMDC, while there were no significant differences in the expression of co-stimulatory molecules between cathepsin-deficient and WT cells. Moreover, both BMDC and BMM from Ctsb-/- mice significantly up-regulated the levels of interleukin 12 (IL-12) expression, a key Th1-inducing cytokine. These findings indicate that Ctsb-/- BMDC display more pro-Th1 properties than their WT and Ctsl-/- counterparts, and therefore suggest that Ctsb down-regulates the Th1 response to L. major. Moreover, they propose a novel role for Ctsb as a regulator of cytokine expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen Presentation
  • Cathepsin B / deficiency
  • Cathepsin B / immunology*
  • Cathepsin L / immunology
  • Dendritic Cells / immunology*
  • Disease Models, Animal
  • Female
  • Interleukin-12 / biosynthesis
  • Interleukin-12 / immunology
  • Leishmania major / immunology*
  • Leishmaniasis / immunology*
  • Macrophages / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Th1 Cells / immunology*
  • Up-Regulation

Substances

  • Interleukin-12
  • Cathepsin B
  • Cathepsin L

Grants and funding

This work was supported by grants from the Deutsche Forschungsgemeinschaft, including the Collaborative Research Center 630, and IJGL was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Würzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.